ConductScience.org, home

Paper35945641

Role of m6A writers, erasers and readers in cancer.

Fang Z and 6 others. Exp Hematol Oncol, 2022. Cited by 213 papers, by iCite.

Cite this record

ConductScience Library. Role of m6A writers, erasers and readers in cancer. Papers, record 35945641. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35945641

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Role of m6A writers, erasers and readers in cancer.
PubMed
Journal
Exp Hematol Oncol
PubMed
Year
2022
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
213
iCite
Relative citation ratio, by iCite
14.8
iCite
Revised in PubMed
2022-08-13
PubMed

Authors7

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Fang ZZhen
2Mei WWentong
3Qu CChang
4Lu JJiongdi
5Shang LLiang
6Cao FFeng
7Li FFei

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Z171100001017077Beijing Municipal Science & Technology CommissionPubMed

Source PubMed

Download CSV of grants

References323

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
125670861MicroRNA-873 (miRNA-873) inhibits glioblastoma tumorigenesis and metastasis by suppressing the expression of IGF2BP1.J Biol Chem2015https://conductscience.org/library/papers/25670861PubMed
233054406M6A Demethylase FTO Plays a Tumor Suppressor Role in Thyroid Cancer.DNA Cell Biol2020https://conductscience.org/library/papers/33054406PubMed
332956555Downregulation of m6 A reader YTHDC2 promotes tumor progression and predicts poor prognosis in non-small cell lung cancer.Thorac Cancer2020https://conductscience.org/library/papers/32956555PubMed
433533172Kinase GSK3β functions as a suppressor in colorectal carcinoma through the FTO-mediated MZF1/c-Myc axis.J Cell Mol Med2021https://conductscience.org/library/papers/33533172PubMed
528809393Ythdc2 is an N6-methyladenosine binding protein that regulates mammalian spermatogenesis.Cell Res2017https://conductscience.org/library/papers/28809393PubMed
632805088The FTO/miR-181b-3p/ARL5B signaling pathway regulates cell migration and invasion in breast cancer.Cancer Commun (Lond)2020https://conductscience.org/library/papers/32805088PubMed
732449584m6 A demethylase ALKBH5 promotes proliferation of esophageal squamous cell carcinoma associated with poor prognosis.Genes Cells2020https://conductscience.org/library/papers/32449584PubMed
834301762M6A Demethylase ALKBH5 Regulates PD-L1 Expression and Tumor Immunoenvironment in Intrahepatic Cholangiocarcinoma.Cancer Res2021https://conductscience.org/library/papers/34301762PubMed
929399123MicroRNA-124-3p inhibits cell growth and metastasis in cervical cancer by targeting IGF2BP1.Exp Ther Med2018https://conductscience.org/library/papers/29399123PubMed
1026121403Single-nucleotide-resolution mapping of m6A and m6Am throughout the transcriptome.Nat Methods2015https://conductscience.org/library/papers/26121403PubMed
1132323801METTL14 promotes the migration and invasion of breast cancer cells by modulating N6‑methyladenosine and hsa‑miR‑146a‑5p expression.Oncol Rep2020https://conductscience.org/library/papers/32323801PubMed
1232854717Roles of METTL3 in cancer: mechanisms and therapeutic targeting.J Hematol Oncol2020https://conductscience.org/library/papers/32854717PubMed
1334162562IGF2BP1/UHRF2 Axis Mediated by miR-98-5p to Promote the Proliferation of and Inhibit the Apoptosis of Esophageal Squamous Cell Carcinoma.Ann Clin Lab Sci2021https://conductscience.org/library/papers/34162562PubMed
1433059689Connecting METTL3 and intratumoural CD33+ MDSCs in predicting clinical outcome in cervical cancer.J Transl Med2020https://conductscience.org/library/papers/33059689PubMed
1531281898Single-base mapping of m6A by an antibody-independent method.Sci Adv2019https://conductscience.org/library/papers/31281898PubMed
1633094561IGF2BP3 facilitates cell proliferation and tumorigenesis via modulation of JAK/STAT signalling pathway in human bladder cancer.J Cell Mol Med2020https://conductscience.org/library/papers/33094561PubMed
1734496932ALKBH5-HOXA10 loop-mediated JAK2 m6A demethylation and cisplatin resistance in epithelial ovarian cancer.J Exp Clin Cancer Res2021https://conductscience.org/library/papers/34496932PubMed
1833207095Endometrial Cancer.N Engl J Med2020https://conductscience.org/library/papers/33207095PubMed
1933023892The RNA m6A Reader YTHDF2 Maintains Oncogene Expression and Is a Targetable Dependency in Glioblastoma Stem Cells.Cancer Discov2021https://conductscience.org/library/papers/33023892PubMed
2034335955Silencing of METTL3 effectively hinders invasion and metastasis of prostate cancer cells.Theranostics2021https://conductscience.org/library/papers/34335955PubMed

See all 323 referencesDownload CSV of references

Cited by156

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 213 citations.

PMIDTitleJournalYearIn PapersSource
42840625The methylation pattern of osimertinib resistance: prospects for diagnosis and treatment of NSCLC.Front Oncol2026https://conductscience.org/library/papers/42840625PubMed
42665759Mechanistic Study of m5C Modification in Stem Cell Differentiation and Disease Regulation.Stem Cell Rev Rep2026https://conductscience.org/library/papers/42665759PubMed
42435175Influence of RNA Modifications on Cancer Metabolism: Interplay with Hypoxia and Therapeutic Implications.Adv Exp Med Biol2026https://conductscience.org/library/papers/42435175PubMed
42399631GDPPH1 induces cell cycle arrest by downregulation of CDK4/Cyclin D1 via the m6A-METTL14-YTHDF2 axis, attenuating glioblastoma progression.Cell Death Dis2026https://conductscience.org/library/papers/42399631PubMed
42328436RNA variation as the driver of genomic efficiency and phenotypic complexity.Int J Biol Sci2026https://conductscience.org/library/papers/42328436PubMed
42240709FTO Deficiency Inhibits Vascular Endothelial Cell Apoptosis and Improved Mitophagy in Obesity-Related Hypertension by Enhancing NDRG1 m6A Methylation.Biochem Genet2026https://conductscience.org/library/papers/42240709PubMed
42223535The crucial role of m6A methylation modification in nasopharyngeal carcinoma.Discov Oncol2026https://conductscience.org/library/papers/42223535PubMed
42218253ALKBH5 aggravates scarring after glaucoma surgery via m6A-YTHDF2-mediated NLRP3 mRNA stabilization.Cell Death Differ2026https://conductscience.org/library/papers/42218253PubMed
42144760PDE4D Mediates the Cardiac Ischemia Reperfusion Injury and Is m6A Modified by METTL14.Korean Circ J2026https://conductscience.org/library/papers/42144760PubMed
42113318RBM15/IGF2BP2-PTPRH m6A regulatory axis in non-small cell lung cancer.Cell Oncol (Dordr)2026https://conductscience.org/library/papers/42113318PubMed
42102015Pyroptosis Regulated by N6-Methyladenosine Modification: Implications for Pyroptosis-Related Disease Therapy.J Innate Immun2026https://conductscience.org/library/papers/42102015PubMed
42093977RNA methylation in urological cancers: regulatory logic, biological functions, and clinical relevance.Front Immunol2026https://conductscience.org/library/papers/42093977PubMed
42031695Uncovering a role for METTL13 in malignant transformation of human hematopoietic stem cells and in the progression of pediatric leukemia.Cell Death Dis2026https://conductscience.org/library/papers/42031695PubMed
41949706Targeting the RNA-binding motif protein 15 suppresses prostate cancer progression and hormone therapy resistance by promoting androgen receptor degradation.Mol Biomed2026https://conductscience.org/library/papers/41949706PubMed
41878447Integrative single-cell, spatial, and bulk transcriptomics reveal an FMR1-FTO axis linked to the immune-excluded phenotype in gastric cancer.Front Immunol2026https://conductscience.org/library/papers/41878447PubMed
41852637The Future of Epigenetics: Emerging Technologies and Clinical Applications.ACS Pharmacol Transl Sci2026https://conductscience.org/library/papers/41852637PubMed
41827726m6A RNA Methylation Promotes the Melanoma Metastasis Mediated by Extracellular Vesicle miR-23a-5p.Cancers (Basel)2026https://conductscience.org/library/papers/41827726PubMed
41800248Interaction between m6A and YAP1 mechanotransduction pathways is essential for mechanical memory and matrix remodeling in pancreatic cancer.Int J Biol Sci2026https://conductscience.org/library/papers/41800248PubMed
41776401ALKBH5 promotes ovarian cancer progression by activating Notch2 signaling.Biol Proced Online2026https://conductscience.org/library/papers/41776401PubMed
41764519SERPINA4 facilitates colorectal cancer progression through m⁶A-dependent stabilization.J Transl Med2026https://conductscience.org/library/papers/41764519PubMed

See all 156 cited byDownload CSV of cited by

Genes165

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
ABCB15243PubTator's text mininghttps://conductscience.org/library/genes/5243NCBI Gene
AKT1207PubTator's text mininghttps://conductscience.org/library/genes/207NCBI Gene
AKT2208PubTator's text mininghttps://conductscience.org/library/genes/208NCBI Gene
ALKBH554890PubTator's text mininghttps://conductscience.org/library/genes/54890NCBI Gene
ASB251676PubTator's text mininghttps://conductscience.org/library/genes/51676NCBI Gene
ASPM259266PubTator's text mininghttps://conductscience.org/library/genes/259266NCBI Gene
ATG59474PubTator's text mininghttps://conductscience.org/library/genes/9474NCBI Gene
AURKB9212PubTator's text mininghttps://conductscience.org/library/genes/9212NCBI Gene
BAX581PubTator's text mininghttps://conductscience.org/library/genes/581NCBI Gene
BCL2596PubTator's text mininghttps://conductscience.org/library/genes/596NCBI Gene
BIRC2329PubTator's text mininghttps://conductscience.org/library/genes/329NCBI Gene
BRD965980PubTator's text mininghttps://conductscience.org/library/genes/65980NCBI Gene
CBLL179872PubTator's text mininghttps://conductscience.org/library/genes/79872NCBI Gene
CBLL2158506PubTator's text mininghttps://conductscience.org/library/genes/158506NCBI Gene
CCNB1891PubTator's text mininghttps://conductscience.org/library/genes/891NCBI Gene
CCND1595PubTator's text mininghttps://conductscience.org/library/genes/595NCBI Gene
CCNG2901PubTator's text mininghttps://conductscience.org/library/genes/901NCBI Gene
CD27429126PubTator's text mininghttps://conductscience.org/library/genes/29126NCBI Gene
CDC25B994PubTator's text mininghttps://conductscience.org/library/genes/994NCBI Gene
CDK1983PubTator's text mininghttps://conductscience.org/library/genes/983NCBI Gene

See all 165 genesDownload CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/35945641

GET https://conductscience.org/api/papers/v1/35945641/references?page=2